| Financial Year |
March 31 2023 |
| Monetary Funds |
441,917,323.47 |
| Held-for-trading Financial Assets |
167,027,301.39 |
| Notes Receivable |
86,825,549.16 |
| Accounts Receivable |
597,794,024.08 |
| Advances to Suppliers |
20,064,766.84 |
| Other Receivables |
15,666,609.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
602,225,317.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,453,575.80 |
| Total Current Assets |
1,994,921,173.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,732,847.83 |
| Long-term Equity Investment |
1,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
181,700,402.20 |
| Under-construction Projects |
187,877,114.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,514,710.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,367,609.90 |
| Deferred Income Tax Assets |
24,239,788.96 |
| Other Non-Current Assets |
18,698,596.87 |
| Sub-Total of Non-Current Assets |
551,677,851.01 |
| Total Assets |
2,546,599,024.87 |
| Short-Term Loans |
100,052,364.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,094,117.21 |
| Accounts Payable |
614,952,122.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
142,135,731.75 |
| Taxes Payable |
20,816,644.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,631,354.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,800,211.68 |
| Other Current Liabilities |
23,940,612.36 |
| Sub-Total of Current Liabilities |
1,274,951,456.39 |
| Long-term Loans |
79,428,702.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
833,115.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
110,241,341.86 |
| Total Liabilities |
1,385,192,798.25 |
| Paid-In Capital(Or Share Stock) |
206,608,093.00 |
| Capital Surplus |
297,524,762.85 |
| Surplus Reserve |
76,759,434.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
580,302,292.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,161,406,226.62 |
| Owner's Equity（Stockholder's Equity） |
1,161,406,226.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,546,599,024.87 |
